Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade

被引：41

作者：

Obergrussberger, Alison ^{[1
]}

Friis, Soren ^{[1
]}

Brueggemann, Andrea ^{[1
]}

Fertig, Niels ^{[1
]}

机构：

[1] Nanion Technol, D-80339 Munich, Germany

来源：

EXPERT OPINION ON DRUG DISCOVERY | 2021年 / 16卷 / 01期

关键词：

Automated patch clamp (APC); high-throughput screening (HTS); Patchliner; SyncroPatch; 384i; Qube; QPatch; ion channels; safety pharmacology; drug discovery; channelopathy; CURRENTS; CELLS;

D O I：

10.1080/17460441.2020.1791079

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 5

页数：5

共 30 条

[1]

Becker Nadine, 2020, Curr Protoc Pharmacol, V88, pe70, DOI 10.1002/cpph.70

[2] Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system [J].

Becker, Nadine ;

Stoelzle, Sonja ;

Gopel, Sven ;

Guinot, David ;

Mumm, Patrick ;

Haarmann, Claudia ;

Malan, Daniela ;

Bohlen, Heribert ;

Kossolov, Eugen ;

Kettenhofen, Ralf ;

George, Michael ;

Fertig, Niels ;

Brueggemann, Andrea .

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) :82-87

[3] Reliable identification of cardiac liability in drug discovery using automated patch clamp: Benchmarking best practices and calibration standards for improved proarrhythmic assessment [J].

Brinkwirth, Nina ;

Takasuna, Kiyoshi ;

Doi, Masafumi ;

Becker, Nadine ;

Obergrussberger, Alison ;

Friis, Soren ;

Furukawa, Hatsue ;

Hasegawa, Yuka ;

Oka, Takayuki ;

Ohtsuki, Atsushi ;

Fertig, Niels ;

Stoelzle-Feix, Sonja .

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105

[4] Characterization of a &ITKCNB1 &ITvariant associated with autism, intellectual disability, and epilepsy [J].

Calhoun, Jeffrey D. ;

Vanoye, Carlos G. ;

Kok, Fernando ;

George, Alfred L., Jr. ;

Kearney, Jennifer A. .

NEUROLOGY-GENETICS, 2017, 3 (06)

[5] Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Nav1.5 gain-of-function mutation (G213D) [J].

Calloe, Kirstine ;

Broendberg, Anders K. ;

Christensen, Alex H. ;

Pedersen, Lisbeth N. ;

Olesen, Morten S. ;

Tejada, Maria de los Angeles ;

Friis, Soren ;

Thomsen, Morten B. ;

Bundgaard, Henning ;

Jensen, Henrik K. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 257 :160-167

[6] High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology [J].

Dunlop, John ;

Bowlby, Mark ;

Peri, Ravikumar ;

Vasilyev, Dmytro ;

Arias, Robert .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (04) :358-368

[7] A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm [J].

Fermini, Bernard ;

Hancox, Jules C. ;

Abi-Gerges, Najah ;

Bridgland-Taylor, Matthew ;

Chaudhary, Khuram W. ;

Colatsky, Thomas ;

Correll, Krystle ;

Crumb, William ;

Damiano, Bruce ;

Erdemli, Gul ;

Gintant, Gary ;

Imredy, John ;

Koerner, John ;

Kramer, James ;

Levesque, Paul ;

Li, Zhihua ;

Lindqvist, Anders ;

Obejero-Paz, Carlos A. ;

Rampe, David ;

Sawada, Kohei ;

Strauss, David G. ;

Vandenberg, Jamie I. .

JOURNAL OF BIOMOLECULAR SCREENING, 2016, 21 (01) :1-11

[8]

Food and Drug Administration (FDA), BEN RISK ASS DRUG RE

[9] Functional consequences of a KCNT1 variant associated with status dystonicus and early-onset infantile encephalopathy [J].

Gertler, Tracy S. ;

Thompson, Christopher H. ;

Vanoye, Carlos G. ;

Millichap, John J. ;

George, Alfred L., Jr. .

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (09) :1606-1615

[10] Evolution of strategies to improve preclinical cardiac safety testing [J].

Gintant, Gary ;

Sager, Philip T. ;

Stockbridge, Norman .

NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (07) :457-471

← 1 2 3 →